BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 25913378)

  • 1. Xeroderma pigmentosum: low prevalence of germline XPA mutations in a Brazilian XP population.
    Santiago KM; França de Nóbrega A; Rocha RM; Rogatto SR; Achatz MI
    Int J Mol Sci; 2015 Apr; 16(4):8988-96. PubMed ID: 25913378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutational spectrum of Xeroderma pigmentosum group A in Egyptian patients.
    Amr K; Messaoud O; El Darouti M; Abdelhak S; El-Kamah G
    Gene; 2014 Jan; 533(1):52-6. PubMed ID: 24135642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genotype-phenotype correlation of xeroderma pigmentosum in a Chinese Han population.
    Sun Z; Zhang J; Guo Y; Ni C; Liang J; Cheng R; Li M; Yao Z
    Br J Dermatol; 2015 Apr; 172(4):1096-102. PubMed ID: 25256075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic homogeneity of mutational spectrum of group-A xeroderma pigmentosum in Tunisian patients.
    Messaoud O; Ben Rekaya M; Cherif W; Talmoudi F; Boussen H; Mokhtar I; Boubaker S; Amouri A; Abdelhak S; Zghal M
    Int J Dermatol; 2010 May; 49(5):544-8. PubMed ID: 20534089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prevalent mutation with founder effect in xeroderma pigmentosum group C from north Africa.
    Soufir N; Ged C; Bourillon A; Austerlitz F; Chemin C; Stary A; Armier J; Pham D; Khadir K; Roume J; Hadj-Rabia S; Bouadjar B; Taieb A; de Verneuil H; Benchiki H; Grandchamp B; Sarasin A
    J Invest Dermatol; 2010 Jun; 130(6):1537-42. PubMed ID: 20054342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis of Xeroderma Pigmentosum Groups A and C by Detection of Two Prevalent Mutations in West Algerian Population: A Rapid Genotyping Tool for the Frequent XPC Mutation c.1643_1644delTG.
    Bensenouci S; Louhibi L; De Verneuil H; Mahmoudi K; Saidi-Mehtar N
    Biomed Res Int; 2016; 2016():2180946. PubMed ID: 27413738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical profile and mutation analysis of xeroderma pigmentosum in Indian patients.
    Tamhankar PM; Iyer SV; Ravindran S; Gupta N; Kabra M; Nayak C; Kura M; Sanghavi S; Joshi R; Chennuri VS; Khopkar U
    Indian J Dermatol Venereol Leprol; 2015; 81(1):16-22. PubMed ID: 25566891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expansion of the genotypic and phenotypic spectrum of xeroderma pigmentosum in Chinese population.
    Zhang J; Cheng R; Yu X; Sun Z; Li M; Yao Z
    Photodermatol Photoimmunol Photomed; 2017 Jan; 33(1):58-63. PubMed ID: 27982466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe phenotypes in two Tunisian families with novel XPA mutations: evidence for a correlation between mutation location and disease severity.
    Messaoud O; Rekaya MB; Ouragini H; Benfadhel S; Azaiez H; Kefi R; Gouider-Khouja N; Mokhtar I; Amouri A; Boubaker MS; Zghal M; Abdelhak S
    Arch Dermatol Res; 2012 Mar; 304(2):171-6. PubMed ID: 22081045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic investigation of XPA gene: high frequency of the c.682C>T mutation in Moroccan XP patients with moderate clinical profile.
    Kindil Z; Senhaji MA; Bakhchane A; Charoute H; Chihab S; Nadifi S; Barakat A
    BMC Res Notes; 2017 Dec; 10(1):704. PubMed ID: 29208038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of Big Data to Estimate Prevalence of Defective DNA Repair Variants in the US Population.
    Pugh J; Khan SG; Tamura D; Goldstein AM; Landi MT; DiGiovanna JJ; Kraemer KH
    JAMA Dermatol; 2019 Jan; 155(1):72-78. PubMed ID: 30516811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In silico characterization of a novel pathogenic deletion mutation identified in XPA gene in a Pakistani family with severe xeroderma pigmentosum.
    Nasir M; Ahmad N; Sieber CM; Latif A; Malik SA; Hameed A
    J Biomed Sci; 2013 Sep; 20(1):70. PubMed ID: 24063568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and genetic characteristics of xeroderma pigmentosum in Nepal.
    Espi P; Parajuli S; Benfodda M; Lebre AS; Paudel U; Grange A; Grybek V; Grange T; Soufir N; Grange F
    J Eur Acad Dermatol Venereol; 2018 May; 32(5):832-839. PubMed ID: 29178624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An XPA gene splicing mutation resulting in trace protein expression in an elderly patient with xeroderma pigmentosum group A without neurological abnormalities.
    Takahashi Y; Endo Y; Kusaka-Kikushima A; Nakamaura S; Nakazawa Y; Ogi T; Uryu M; Tsuji G; Furue M; Moriwaki S
    Br J Dermatol; 2017 Jul; 177(1):253-257. PubMed ID: 27603812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel mutation in the XPA gene associated with unusually mild clinical features in a patient who developed a spindle cell melanoma.
    Sidwell RU; Sandison A; Wing J; Fawcett HD; Seet JE; Fisher C; Nardo T; Stefanini M; Lehmann AR; Cream JJ
    Br J Dermatol; 2006 Jul; 155(1):81-8. PubMed ID: 16792756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of a transfected DNA repair gene (XPA) in xeroderma pigmentosum group A cells restores normal DNA repair and mutagenesis of UV-treated plasmids.
    Levy DD; Saijo M; Tanaka K; Kraemer KH
    Carcinogenesis; 1995 Jul; 16(7):1557-63. PubMed ID: 7614689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of Xeroderma Pigmentosum-A Patient-Derived Induced Pluripotent Stem Cell Line for Use As Future Disease Model.
    Ohnishi H; Kawasaki T; Deguchi T; Yuba S
    Cell Reprogram; 2015 Aug; 17(4):268-74. PubMed ID: 26090552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a primarily neurological phenotypic expression of xeroderma pigmentosum complementation group A in a Tunisian family.
    Messaoud O; Ben Rekaya M; Kefi R; Chebel S; Boughammoura-Bouatay A; Bel Hadj Ali H; Gouider-Khouja N; Zili J; Frih-Ayed M; Mokhtar I; Abdelhak S; Zghal M
    Br J Dermatol; 2010 Apr; 162(4):883-6. PubMed ID: 20199544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of DNA binding by human factor xeroderma pigmentosum complementation group A (XPA) provides insight into its interactions with nucleotide excision repair substrates.
    Sugitani N; Voehler MW; Roh MS; Topolska-Woś AM; Chazin WJ
    J Biol Chem; 2017 Oct; 292(41):16847-16857. PubMed ID: 28860187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and molecular epidemiological study of xeroderma pigmentosum in China: A case series of 19 patients.
    Zhou EY; Wang H; Lin Z; Xu G; Ma Z; Zhao J; Feng C; Duo L; Yin J; Yang Y
    J Dermatol; 2017 Jan; 44(1):71-75. PubMed ID: 27607234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.